• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性胃切除术后腹膜冲洗细胞学阳性但无腹膜转移的胃癌患者的生存结果及预后指标

Survival outcomes and prognostic indicators for gastric cancer patients with positive peritoneal wash cytology but no peritoneal metastasis after radical gastrectomy.

作者信息

Kang Wen-Zhe, Zhong Yu-Xin, Ma Fu-Hai, Xue Li-Yan, Xiong Jian-Ping, Ma Shuai, Li Yang, Xie Yi-Bin, Quan Xu, Tian Yan-Tao

机构信息

Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Bejing 100021, China.

出版信息

World J Gastrointest Oncol. 2021 Jan 15;13(1):24-36. doi: 10.4251/wjgo.v13.i1.24.

DOI:10.4251/wjgo.v13.i1.24
PMID:33510847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7805269/
Abstract

BACKGROUND

Positive peritoneal wash cytology with no peritoneal metastasis (CY1P0) is a special type of distant gastric cancer metastasis, which describes a patient with positive peritoneal lavage cytology, but no definitive peritoneal metastasis, and there are no widely accepted treatment guidelines. We enrolled 48 primary CY1P0 gastric cancer patients treated by radical gastrectomy in this study. Our study illustrated the efficacy of radical gastrectomy for CY1P0 gastric cancer patients, and suggested that the pathological N factor and vascular invasion were significant independent risk factors for overall survival (OS).

AIM

To assess the survival of CY1P0 gastric cancer patient post-radical gastrectomy, and to identify factors associated with long-term prognosis.

METHODS

Our study included 48 patients with primary CY1P0 gastric cancer who had radical gastrectomies at the Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China between 2013 and 2018. R0 resection was achieved in all 48 patients. Twelve patients received neoadjuvant chemotherapy. Thirty patients received adjuvant chemotherapy and four received adjuvant chemoradiotherapy. OS statistics were available for 48 patients. Follow-up continued through March 2020. Univariate and multivariate analyses were performed using a Cox proportional hazards model to identify prognostic factors.

RESULTS

Median OS was 22.0 mo (95% confidence interval: 13.366-30.634 mo) post-surgery. Univariate analyses demonstrated that tumor site ( = 0.021), pathological N factor ( = 0.001), pathological T factor ( = 0.028), vascular invasion ( = 0.046), and the level of CA199 prior to initiating therapy ( = 0.002) were significant risk factors for OS. Multivariate analyses demonstrated that pathological N factor ( = 0.001) and vascular invasion ( = 0.031) were significant independent risk factors for OS.

CONCLUSION

This study suggested that radical gastrectomy may be efficient for CY1P0 gastric cancer patient post-radical gastrectomy and the pathological N factor and vascular invasion are significant independent risk factors for OS.

摘要

背景

腹膜冲洗细胞学检查阳性但无腹膜转移(CY1P0)是一种特殊类型的远处胃癌转移,指患者腹膜灌洗细胞学检查阳性,但无明确的腹膜转移,目前尚无广泛认可的治疗指南。本研究纳入了48例接受根治性胃切除术治疗的原发性CY1P0胃癌患者。我们的研究阐述了根治性胃切除术对CY1P0胃癌患者的疗效,并表明病理N因素和血管侵犯是总生存期(OS)的重要独立危险因素。

目的

评估根治性胃切除术后CY1P0胃癌患者的生存情况,并确定与长期预后相关的因素。

方法

我们的研究纳入了48例原发性CY1P0胃癌患者,这些患者于2013年至2018年在中国北京的中国医学科学院肿瘤医院接受了根治性胃切除术。48例患者均实现了R0切除。12例患者接受了新辅助化疗。30例患者接受了辅助化疗,4例接受了辅助放化疗。48例患者可获得OS统计数据。随访持续至2020年3月。采用Cox比例风险模型进行单因素和多因素分析以确定预后因素。

结果

术后中位OS为22.0个月(95%置信区间:13.366 - 30.634个月)。单因素分析表明,肿瘤部位(P = 0.021)、病理N因素(P = 0.001)、病理T因素(P = 0.028)、血管侵犯(P = 0.046)以及开始治疗前CA199水平(P = 0.002)是OS的显著危险因素。多因素分析表明,病理N因素(P = 0.001)和血管侵犯(P = 0.031)是OS的显著独立危险因素。

结论

本研究表明,根治性胃切除术对CY1P0胃癌患者可能有效,且病理N因素和血管侵犯是OS的重要独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/abb91aacd115/WJGO-13-24-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/69590d49a93b/WJGO-13-24-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/9bf46db7cd3a/WJGO-13-24-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/97a713c65784/WJGO-13-24-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/cc3e7d6084af/WJGO-13-24-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/abb91aacd115/WJGO-13-24-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/69590d49a93b/WJGO-13-24-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/9bf46db7cd3a/WJGO-13-24-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/97a713c65784/WJGO-13-24-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/cc3e7d6084af/WJGO-13-24-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf62/7805269/abb91aacd115/WJGO-13-24-g005.jpg

相似文献

1
Survival outcomes and prognostic indicators for gastric cancer patients with positive peritoneal wash cytology but no peritoneal metastasis after radical gastrectomy.根治性胃切除术后腹膜冲洗细胞学阳性但无腹膜转移的胃癌患者的生存结果及预后指标
World J Gastrointest Oncol. 2021 Jan 15;13(1):24-36. doi: 10.4251/wjgo.v13.i1.24.
2
Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy.根治性 D2 胃切除术后腹膜冲洗细胞学阳性而无大体腹膜转移的胃癌的观察性研究。
Sci Rep. 2020 Jun 12;10(1):9549. doi: 10.1038/s41598-020-66637-y.
3
The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.接受根治性胃切除术后序贯 S-1 化疗的腹膜细胞学阳性胃癌患者的生存和预后因素。
Int J Clin Oncol. 2017 Oct;22(5):887-896. doi: 10.1007/s10147-017-1128-8. Epub 2017 Apr 29.
4
[Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].[淋巴管浸润对Ⅰ期胃癌患者根治性胃切除术后预后的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):175-179.
5
[Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].[接受新辅助治疗的胃癌患者术后并发症及其对预后因素的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):160-166. doi: 10.3760/cma.j.cn.441530-20200420-00229.
6
Clinicopathologic characteristics in patients with upper third gastric cancer following radical surgical treatment: A retrospective cohort study.根治性手术治疗后胃上部癌患者的临床病理特征:一项回顾性队列研究。
Medicine (Baltimore). 2018 Nov;97(45):e13017. doi: 10.1097/MD.0000000000013017.
7
[Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].奥沙利铂联合S-1辅助化疗用于D2淋巴结清扫术后局部进展期胃癌患者的安全性和疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):145-152. doi: 10.3760/cma.j.cn.441530-20201016-00561.
8
Prognostic Factors for Gastric Cancer with Cancer Cells in the Peritoneal Cavity.伴有腹腔内癌细胞的胃癌的预后因素
Anticancer Res. 2016 May;36(5):2481-5.
9
[Long-term efficacy of robotic radical total gastrectomy for gastric cancer and analysis of prognostic factors].机器人根治性全胃切除术治疗胃癌的长期疗效及预后因素分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Apr 25;23(4):357-363. doi: 10.3760/cma.j.cn.441530-20200113-00021.
10
[Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].新辅助放化疗联合手术与直接手术治疗食管胃交界部SiewertⅡ型和Ⅲ型腺癌:一项前瞻性随机对照试验的长期预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):128-137. doi: 10.3760/cma.j.cn.441530-20201019-00565.

引用本文的文献

1
Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases.伴有同步腹膜转移的胃癌管理共识指南
Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17361-2.
2
Comparison of Peritoneal Cytology Results Before and After Resection in Gastric Cancer Patients.胃癌患者切除术前与术后腹膜细胞学检查结果的比较
Cureus. 2024 Jul 31;16(7):e65832. doi: 10.7759/cureus.65832. eCollection 2024 Jul.
3
Current treatment strategies for patients with only peritoneal cytology positive stage IV gastric cancer.

本文引用的文献

1
Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.胃癌术后阳性腹腔冲洗液细胞学(CY1)或局限性腹膜转移(P1a)患者行术后化疗的疗效:一项多中心回顾性研究。
Ann Surg Oncol. 2020 Jan;27(1):284-292. doi: 10.1245/s10434-019-07697-x. Epub 2019 Sep 18.
2
The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.接受根治性胃切除术后序贯 S-1 化疗的腹膜细胞学阳性胃癌患者的生存和预后因素。
Int J Clin Oncol. 2017 Oct;22(5):887-896. doi: 10.1007/s10147-017-1128-8. Epub 2017 Apr 29.
3
仅有腹膜细胞学阳性的IV期胃癌患者的当前治疗策略。
World J Clin Cases. 2021 Nov 16;9(32):9711-9721. doi: 10.12998/wjcc.v9.i32.9711.
Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.伴有腹膜转移或腹膜细胞学检查结果阳性的胃癌患者在接受腹腔内和全身化疗后的手术治疗。
Gastric Cancer. 2017 Mar;20(Suppl 1):128-134. doi: 10.1007/s10120-016-0684-3. Epub 2016 Dec 27.
4
Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.腹腔内化疗及腹腔灌洗对胃癌腹膜细胞学阳性的影响:系统评价与荟萃分析
Eur J Surg Oncol. 2016 Sep;42(9):1261-7. doi: 10.1016/j.ejso.2016.03.035. Epub 2016 Apr 19.
5
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.胃切除术加化疗与单纯化疗治疗有单一不可治愈因素的晚期胃癌(REGATTA):一项 3 期随机对照试验。
Lancet Oncol. 2016 Mar;17(3):309-318. doi: 10.1016/S1470-2045(15)00553-7. Epub 2016 Jan 26.
6
The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.广泛术中腹腔灌洗治疗(EIPL)对ⅢB + C期及细胞学阳性胃癌患者的疗效。
Int J Clin Oncol. 2016 Apr;21(2):289-294. doi: 10.1007/s10147-015-0892-6. Epub 2015 Aug 22.
7
Comparison of Neoadjuvant Chemotherapy to Surgery Followed by Adjuvant Chemotherapy in Japanese Patients with Peritoneal Lavage Cytology Positive for Gastric Carcinoma.日本胃癌腹腔冲洗细胞学阳性患者新辅助化疗与手术加辅助化疗的比较
Anticancer Res. 2015 Sep;35(9):4859-63.
8
Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.术前血清白蛋白降低和无腹膜播散可能是细胞学检查阳性的进展期胃癌长期生存的预测因素。
Eur J Surg Oncol. 2015 Oct;41(10):1324-32. doi: 10.1016/j.ejso.2015.05.021. Epub 2015 Jul 29.
9
Prospective clinical trial of diagnostic peritoneal lavage to detect positive peritoneal cytology in patients with gastric cancer.前瞻性临床研究诊断性腹腔灌洗术检测胃癌患者腹腔细胞学阳性。
J Surg Oncol. 2013 Jun;107(8):794-8. doi: 10.1002/jso.23328. Epub 2013 Mar 26.
10
Prognostic significance of peritoneal washing cytology in patients with gastric cancer (Br J Surg 2012; 99: 397-403).
Br J Surg. 2012 Aug;99(8):1166; author reply 1166-7. doi: 10.1002/bjs.8855.